Why You May Want a Second Opinion for Recurrent Ovarian Cancer — and How to Get One - Everyday Health
Why You May Want a Second Opinion for Recurrent Ovarian Cancer — and How to Get One Everyday Health
2555 материалов по теме, собраны автоматически из проверенных источников
Why You May Want a Second Opinion for Recurrent Ovarian Cancer — and How to Get One Everyday Health
Атлас SPanC-Lnc выявил почти 95 тысяч неизвестных молекул для борьбы с раком pronedra.ru
Онколог назвал признаки самого летального вида рака - ТИА TverNews
NCI Assay Validation of Cancer Biomarkers UH3 Grant 2026 Oncodaily
A QIMR Berghofer-led team has developed a powerful tool to explore and understand the mysterious workings of the vast region of the human genome once dismissed as "junk DNA," discovering thousands of molecules that could hold the key to new precision cancer treatments.
UVM Cancer Center, FDA announce new treatment for pancreatic cancer WPTZ
A scientist at Cincinnati Children's who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the quest. Nancy Ratner, Ph.D., and a team of nine co-authors are reporting that a novel class of medications—known as KRAS…
Dr. Duane Mitchell selected to lead UF Health Cancer Institute UF Health
The science behind an ambitious cancer strategy New Scientist
Внутрипросветная эндоскопическая диагностика: всё о нулевой стадии рака в программе «Здоровая среда» Область 45
A continuing resolution awaiting President Donald Trump’s signature that would avert a government shutdown would also have implications for the federal grantmaking process. The U.S. House of Representatives passed H.R. 6500 on Sept. 1. If signed, the stopgap funding bill will temporarily block proposed changes to the…
B Подмосковье запустили онлайн‑тесты на риски рака Рамблер
Рак прикрывается сахаром: ученые нашли новый механизм защиты опухолей Vesti.az
Adam Dicker: Celebrating a Summer of Progress in Radiation Oncology at Jefferson Oncodaily